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ABSTRACT
The aim of this study is to determine the activities of some selected liver enzymes amongst apparently healthy 
subjects of different blood groups. The study involved 95 apparently healthy students of Ambrose Alli University, 
Ekpoma, Edo State, Nigeria, between the ages of 18-30, and distributed as follows; blood group O (30), group AB 
(18), group A (22) and blood group B (25). Blood samples were collected from the antecubital vein and separated to 
obtain serum. The activities of Alkaline phosphatase (ALP), Aspartate amino transferase (AST) and Alanine amino 
transferase (ALT) in the serum were determined using the spectrophometric method and the results were compared 
using SPSS (version 15). The results showed that the activities of AST and ALT were not significantly different
(p>0.05) among the blood groups. However, the activity of ALP was significantly different (p<0.05) from those of 
blood group A, AB and O. Based on the findings of this study therefore, ABO blood group variations may have an 
influence on some liver enzymes activity.
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INTRODUCTION
Host genetic and environmental factors may be an important factor in the genesis of diseases. ABO blood groups are 
one set of agglutinogens (antigens), which are genetically determined carbohydrate molecules carried on the surface 
of the red blood cells. ABO blood groups have shown association with various non-infectious and infectious 
diseases (Jeffery and Kenneth, 2005; Dey and Cederbaum, 2006; Umit et al., 2008). In most people A and B 
antigens are secreted by the cells and are present in the blood circulation. It seems that non-secretors are susceptible 
to variety of infections and the possible pathogenesis for this susceptibility is dependent on the fact that soluble 
blood group proteins may block binding to polysaccharide on cells (Jeffery and Kenneth, 2005). It has been asserted 
that the progression of fibrosis in hepatitis C virus (HCV) infection is a process in which genes interact with 
environmental factors and ABO blood groups distribution is associated with thrombotic event; non-O blood groups 
increase the risk of these venous thromboses (Armelle et al., 2006).
On the other hand, liver enzymes are a group of enzymes, that include Alanine Aminotransferase (ALT), Aspartate 
Aminotransferase (AST) (collectively called the transaminases or aminotransferases), Alkaline phosphatases (ALP) , 
gamma glutamyl transferase, glutathione-s-transferase, serum cholinesterase, glutamate dehydrogenase, and 5’-
nucleotidase (David and Michael, 2005). The most common however are ALT and ALP. Clinically, the assessment 
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of serum or plasma concentration of these enzymes can be useful to access the function of the liver in health and 
disease condition (Ochei and Kolhatkar, 2000). 
Of interest however is the fact that ABO blood group has shown some association with various liver diseases 
(Armelle et al., 2006). In fact, marked differences in plasma or serum concentration of some liver and intestinal 
enzymes (Adamo, 2010) leading to marked differences in nutritional benefit from a diet, enhances susceptibility to 
diseases. Blood group O patients have been reported to be more resistant to the sequelae of acute viral hepatis (Erin 
et al., 2008). Also, Type A have been previously found to be associated with the risk of several malignancies, 
including gastric cancer, pancreatic cancer, epithelial ovarian and skin cancer (Greenwell,1997), which may warrant 
an elevation of the liver enzymes. However, information about the association of ABO blood group with the 
difference in activity of the liver enzymes is scarce. 
Furthermore, two recent genome-wide association studies (GWAS) suggests that the ABO blood group antigen may 
affect systemic inflammatory state. Specifically, Single Nucleotide Polymorphism (SNPs) at the ABO locus was 
associated with two serum markers of inflammation (TNF-alpha) and soluble intercellular adhesion molecule 1 
(sICAM-1) (Melzer et al., 2008; Pare et al., 2008). Also, enhanced expression of TNF- alpha has been is associated 
with liver inflammation and hepatocarcinogenesis (Pare et al., 2008). These indicated a possible link between ABO 
blood groups and liver enzymes. Therefore, this study assesses the activities of ALP, ALT and AST in apparently 
healthy blood group A, B, AB and O individuals.
MATERIALS AND METHODS
Area of Study: This study was carried out in Ekpoma, the Local Government Area Headquarter of Esan west Local 
Government Area, Edo State, Nigeria. It is located at latitide 60 45’N and longitude 60 08E. Ekpoma is a moderately 
populated area and the major occupation of the people is farming and trading. Their main water is rain water stored 
up in underground wells. It is usually cold at night and very hot during the day with an undulating topography 
(Cartographic Laboratory, 2011).
Sample Size: A total of Ninety-Five (95) apparently healthy subjects consisting of Thirty (30) blood group O, 
Eighteen (18) blood group AB, Twenty-Two blood (22) group A and Twenty-five (25) blood group  B  individuals 
were used for this study. All the subjects were between the ages of 18-30 years and are students from Ambrose Alli 
University, Ekpoma, Edo State.
Inclusion Criteria: Only apparently healthy male and female between the ages of 18 and 30 years were sampled in 
this study.
Sample Collection: 5 mls of blood was collected from the anticubital vein of the subjects with the aid of needle and 
syringe and serum was separated after clotting had occurred. The serum samples were stored frozen at -70o until 
analysis was required.
Biochemical Assay: The ABO blood groups of the samples were determined via cell / forward grouping using Tile 
method as described by Cheesbrough, (2000). Estimation of Serum ALP was  done using the method described by 
Rec (1972), while estimation of Serum Alanine Amino Tranferase (ALT) and Aspartate Amino Transferase (AST) 
was done using the Colorimetric Method of Rietman and Frankel (1957).
Statistical Analysis: Statistical analysis was performed using One way analysis of variance with the aid of a 
statistical package SPSS (version 15.0) software. The comparisons were done at 95 % confidence level (P < 0.05 –
significance). The results were presented as mean ± standard deviation (SD), p-value and F-value.
Results
The results of this study as shown below (Table 1), reveal that the serum level of ALP was significantly different 
(P<0.05) among the various Blood groups. Detailed comparison between two groups revealed that the ALP level 
was significantly different (P<0.05) in blood group A when compared to AB and O.
However, the serum level of AST and ALT were not significantly different (P>0.05) among the various Blood 
groups. Similarly, comparison between the two blood groups were also found not to be significantly different 
(P>0.05).
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ALP(IU/L) 77.50±21.71a 70.00±18.31b 55.28±12.46ab 62.73±22.53a 4.862 0.004
AST (IU/L) 22.32±19.67 24.84±6.70 21.33±6.70 23.50±6.11 0.411 0.746
ALT (IU/L) 6.64±5.22 5.44±3.08 4.17±1.25 5.40±6.02 0.979 0.406
N=Number of subjects; S.D=Standard Deviation, ALP=Alkaline Phosphatase, AST=Aspartate Amino-Transferase, 
ALT=Alanine Amino-Transferase, Values in a row having same superscript are significantly different at P<0.05.
DISCUSSION
The findings of this study are in line with the work of Hisham and Hind (2010). Hisham and Hind (2010), reported 
that there was no significant relationship between the activities of ALT amongst ABO blood groups in Cohort of 
healthy blood donors and volunteers from Saudi Arabia. Although the reason was not been addressed, Hisham and 
Hind (2010) stated however, that normal serum liver enzyme (particularly ALT) in selected population varies 
according to sex, age and ethnic origin.
In this study, a significant increase in the ALP activity of blood type A individuals when compared to blood type AB 
and O individuals was observed. The increase in the activity of ALP in blood type A individuals may be due to 
difference in their cytokine binding capability which in turn stimulate increase enzyme activity. Okada et al, (1987); 
Melzer et al., (2008); Pare et al., (2008) and Barbalic et al., (2009) found that, ABO blood group was associated 
with differences in binding capability with certain cytokines including EGF, TNF-α, sICAM-1, E-Selectin and P-
Selectin. The EGF receptor (EGFR) plays a link between inflammation and liver diseases (liver cancer) (Berasain et 
al., 2009), and EGF gene polymorphisms have been reported to be associated with inflammation. The binding of 
endothelial EGF to EGFR is different in blood type A. There is growing evidence that ABO blood type is 
significantly associated with variation in the levels of a number of biomarkers.
Furthermore, a large scale genomic study by Barbalic et al., (2009) revealed that sP-Selectin levels were also 
associated with ABO gene variants and the association was accounted for by AI allele of ABO blood group. ABO 
gene product related glycossylation might influence sheding/cleavages of these biomarkers from the endothelial 
probably by glycosylation of P-Selectin, E-Selectin and ICAM-1 (Otto et al., 2006). Glycosylation could also affect 
the clearance sP-Selectin  sE-Selectin and sICAM-I from blood. Decreased cleavage of adhesion molecules from 
endothelial cells association with A allele would mean more adhesion and inflammation, leading to a possible rise in 
enzyme activity. These also explain the reason for the increase risk of blood type A individuals to Hepatocellular 
Carcinoma, HCC (Qiang et al., 2011). This finding is also in partial agreement with the work of Armelle et al, 
(2006).
In the study by Armelle et al (2006) on the severity of fibrosis in chronic viral hepatitis C in association with blood 
groups, it was observed that group A, B and AB ABO were associated with thrombotic events that can in turn, boost 
enzyme activities. ABO blood group thrombotic effect is thought to be at least in part, mediated through its
influence on plasma level of factor VIII (Koster et al., 1995; kraajenhagen et al., 2000). In addition non-O blood 
groups were associated with increase fibrosis, even after adjustment on gender, age, alcohol consumption and 
duration of infection. Qiang et al., (2011) reported that the increase activity is traceable to the increasing binding 
capability of blood group A to certain cytokines (e.g EtGF, TNF-α) than blood type O.
On the other hand, the finding of this study are not in line with the work of Bamfold et al., (1965) and Adamo, 
(2010) in which increase ALP activity was find in blood type O and B individuals than A. They based their 
argument on the larger contribution by intestinal alkaline phosphatase (IAP) in blood type O and B individuals with 
O individuals having the highest contribution. Blood types B makes considerable amount of intestinal alkaline 
phosphatase (IAP) as well, but type A’s make little, which is one of the strongest indicators for long term benefit of 
a low-fat diet in type A, as regards susceptibility to cardiovascular disease and cancer. This contribution is however 
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due to ALP-1 and ALP-2 as intestinal isoenzyme ALP-3 is present in small quantities in group O and B individuals 
(Ramnik, 2006). This finding that there was a significant increase in the ALP activity of blood type B when 
compared to blood type AB individuals is also in line with the work of Bamfold et al. (1965) and Adamo (2010).
Our findings suggest therefore, that the ABO blood type is associated with difference in the activity of ALP. 
However these findings indicate the need for more accurate definition of normal ALP, AST and ALT activity among 
young adults. This will ultimately lead to more accurate diagnosis and follow-up of liver diseases. Also, further 
research should be carried out in order to come to determine the activity of ALP, AST and ALT in ABO blood 
groups.
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